UCB SA (Belgium) Performance
| UCB Stock | EUR 185.10 3.00 1.65% |
UCB SA has a performance score of 1 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of 0.16, which indicates not very significant fluctuations relative to the market. As returns on the market increase, UCB SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding UCB SA is expected to be smaller as well. UCB SA now owns a risk of 1.42%. Please validate UCB SA coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to decide if UCB SA will be following its current price history.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in UCB SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable fundamental drivers, UCB SA is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 1.3 B | |
| Total Cashflows From Investing Activities | -487 M |
UCB |
UCB SA Relative Risk vs. Return Landscape
If you would invest 18,245 in UCB SA on November 28, 2024 and sell it today you would earn a total of 265.00 from holding UCB SA or generate 1.45% return on investment over 90 days. UCB SA is generating 0.0336% of daily returns assuming 1.4192% volatility of returns over the 90 days investment horizon. Simply put, 12% of all stocks have less volatile historical return distribution than UCB SA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
UCB SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for UCB SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as UCB SA, and traders can use it to determine the average amount a UCB SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0237
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | UCB |
Estimated Market Risk
| 1.42 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average UCB SA is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of UCB SA by adding it to a well-diversified portfolio.
UCB SA Fundamentals Growth
UCB Stock prices reflect investors' perceptions of the future prospects and financial health of UCB SA, and UCB SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on UCB Stock performance.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0468 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 15.81 B | |||
| Shares Outstanding | 189.96 M | |||
| Price To Earning | 17.19 X | |||
| Price To Book | 1.55 X | |||
| Price To Sales | 2.39 X | |||
| Revenue | 5.78 B | |||
| EBITDA | 1.6 B | |||
| Cash And Equivalents | 1.28 B | |||
| Cash Per Share | 6.77 X | |||
| Total Debt | 1.97 B | |||
| Debt To Equity | 23.90 % | |||
| Book Value Per Share | 46.94 X | |||
| Cash Flow From Operations | 1.55 B | |||
| Earnings Per Share | 4.57 X | |||
| Total Asset | 14.21 B | |||
| Retained Earnings | 2.92 B | |||
| Current Asset | 2.84 B | |||
| Current Liabilities | 3.06 B | |||
About UCB SA Performance
Assessing UCB SA's fundamental ratios provides investors with valuable insights into UCB SA's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the UCB SA is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
UCB SA, a biopharmaceutical company, researches, develops, manufactures, sells, and distributes biopharmaceutical solutions for people living with neurology and immunology conditions. The company was founded in 1928 and is headquartered in Brussels, Belgium. UCB SA operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 6828 people.Things to note about UCB SA performance evaluation
Checking the ongoing alerts about UCB SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for UCB SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 38.0% of the company outstanding shares are owned by insiders |
- Analyzing UCB SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether UCB SA's stock is overvalued or undervalued compared to its peers.
- Examining UCB SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating UCB SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of UCB SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of UCB SA's stock. These opinions can provide insight into UCB SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for UCB Stock Analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.